Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with 131I-anti-CD20 antibody and stem cell rescue

Karin Hohloch, Carsten Oliver Sahlmann, Vijai J. Lakhani, Gerald Wulf, Bertram Glaß, Justin Hasenkamp, J. Meller, J. Riggert, Lorenz Trümper, Frank Griesinger

Annals of Hematology · 2011 · 16 citations · 23 references

DOIFull text

Open access

Concepts

References

23